Human Anti-IGHE (clone Omalizumab) scFv-Fc Chimera

CAT#: VS-0425-FY120

Anti-IGHE scFv-Fc is a recombinant antibody designed to target Immunoglobulin E (IgE), a key player in allergic reactions. The scFv portion provides specific binding to IgE, while the Fc region enhances stability and may offer additional benefits. This format is being developed to neutralize IgE, aiming to prevent it from triggering allergic responses.

Gene Expression
Figure 1 RNA cell line category: Cell line enriched (U-266/70)

Specifications

  • Immunogen
  • Human IgE protein.
  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human IGHE
  • Species Reactivity
  • Human
  • Clone
  • Omalizumab
  • Applications
  • ELISA, Blocking
  • Related Disease
  • Toxocariasis and Allergic Rhinitis

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • ELISA: 0.1 μg/mL
    The optimal dilution concentration is determined by the experiment.

Target

  • Alternative Names
  • Immunoglobulin Heavy Constant Epsilon
  • Long Name
  • Immunoglobulin Heavy Constant Epsilon
  • Cellular Localization
  • Cell membrane, Secreted
  • Post Translation Modifications
  • Glycosylation at Asn21, Asn49, Asn99, Asn146, Asn252, Asn264, and Asn275
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyConnect IGHE_HUMAN
    Glycosylation from GlyGen 8 sites, 96 N-linked glycans (8 sites)
  • Function
  • Constant region of immunoglobulin heavy chains.
    Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes.
    In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells.
    Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens.
    The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain.
    Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen.
    The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. IGHE_HUMAN,P01854
    [Isoform 1]: Constant region of secreted IgE, also known as the Fc region of IgE antibody.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0425-FY120. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Clone Omalizumab"

See other products for "IGHE"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NABL-092 Recombinant Anti-human IGHE VHH Single Domain Antibody WB, ELISA, IHC, FC, FuncS Llama VHH
CAT Product Name Application Type
TAB-755 Anti-IGHE Recombinant Antibody (TAB-755) Neut, ELISA, IF, IP, FuncS, FC, ICC IgG1 - kappa
TAB-007 Anti-Human IGHE Recombinant Antibody (Omalizumab) WB, ELISA, IP, FC, FuncS, Neut, IF IgG1 - kappa
CAT Product Name Application Type
AGTO-L061R anti-IGHE immunotoxin (Fab)-RTA Cytotoxicity assay, Functional assay
CAT Product Name Application Type
AFC-TAB-007 Afuco™ Anti-IGHE ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-007) ELISA, IP, FC, FuncS, Neut ADCC enhanced antibody
AFC-TAB-255 Afuco™ Anti-IGHE ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-255) IP, IF, FuncS, FC, Neut ADCC enhanced antibody
AFC-TAB-755 Afuco™ Anti-IGHE ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-755) Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody
CAT Product Name Application Type
VS-0425-YC368 Recombinant Anti-IGHE Vesicular Antibody, EV Displayed (VS-0425-YC368) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-YC218 Recombinant Anti-IGHE (HLP motif x FcεRI binding site) Biparatopic Antibody, Tandem scFv ELISA, FC, IF, IP, Neut Tandem scFv
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare